Agreement with Health House for distribution of Satipharm CBD Gelpell® Capsules throughout Australia, New Zealand and Asia.
March 27, 2019, Satipharm Ltd. today announced that it has entered into an agreement to become a supplier to the renowned medicinal cannabis wholesale & distribution business, Health House International.
Under the terms of the agreement, Satipharm will supply Health House with Satipharm CBD 50mg Gelpell® capsules. The product will continue its availability in Australia, while expanding distribution to New Zealand and Asia where and when legal.
Under the agreement, Health House will distribute Satipharm’s medicinal cannabis products to their existing network of pharmacies while also supporting healthcare professionals with Satipharm product information. Health House International is one of the major wholesalers to Australian pharmacies for medicinal cannabis. In May 2017 they imported one of the first legal international medicinal cannabis shipments into Australia.
Pharmacist, CEO and founder of Health House Paul Mavor said: “The addition of Satipharm’s 50mg Gelpell® capsules to our range allows us to provide clinically proven, high-quality CBD to customers. The capsule is a pharmaceutically elegant and convenient dosage form for those who have been prescribed CBD.”
Satipharm is a health and wellness company which is specialised in the development and manufacture of cannabinoid-based products from the cannabis plant. Our mission is to deliver the highest quality products that are designed specifically with the needs of our customers in mind.
About Health House
Health House International was the first medical cannabis importer into Australia and currently wholesales to pharmacies and researchers around the country. They have a team of pharmacists that can counsel prescribers on strengths, dosage, side effects and interactions. They offer a next business day delivery service for their range of medical cannabis products for authorised patients.